Galera Therapeutics, Inc. (GRTX)
OTCMKTS · Delayed Price · Currency is USD
0.0239
+0.0019 (8.64%)
Feb 12, 2026, 1:56 PM EST
Galera Therapeutics Employees
Galera Therapeutics had 3 employees as of June 30, 2025.
Employees
3
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,995,333
Market Cap
1.80M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 3 | - | - |
| Mar 31, 2025 | 3 | -4 | -57.14% |
| Dec 31, 2024 | 3 | -4 | -57.14% |
| Dec 31, 2023 | 7 | -24 | -77.42% |
| Dec 31, 2022 | 31 | 1 | 3.33% |
| Dec 31, 2021 | 30 | -8 | -21.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Carisma Therapeutics | 46 |
| International Stem Cell | 32 |
| Evofem Biosciences | 32 |
| ZyVersa Therapeutics | 7 |
| Sigyn Therapeutics | 4 |
Galera Therapeutics News
- 4 months ago - Galera Therapeutics (GRTX) Sells Asset Portfolio to Biossil - GuruFocus
- 4 months ago - Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million - GlobeNewsWire
- 1 year ago - Galera Therapeutics completes acquisition of Nova Pharmaceuticals - GlobeNewsWire
- 1 year ago - Galera Announces Board Approval of Complete Liquidation and Dissolution - GlobeNewsWire
- 1 year ago - Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 1 year ago - Galera Adopts Limited Duration Stockholder Rights Agreement - GlobeNewsWire
- 2 years ago - Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 2 years ago - Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates - GlobeNewsWire